121 related articles for article (PubMed ID: 15894692)
1. Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Castle PE; Schiffman M; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Wacholder S; Lorincz AT
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1311-4. PubMed ID: 15894692
[TBL] [Abstract][Full Text] [Related]
2. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
3. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
4. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
Gravitt PE; Kovacic MB; Herrero R; Schiffman M; Bratti C; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Rodriguez AC; Burk RD
Int J Cancer; 2007 Dec; 121(12):2787-93. PubMed ID: 17722112
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
Thomsen LT; Frederiksen K; Munk C; Junge J; Iftner T; Kjaer SK
Int J Cancer; 2015 Jul; 137(1):193-203. PubMed ID: 25471319
[TBL] [Abstract][Full Text] [Related]
6. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
7. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.
Massad LS; Xie X; Burk RD; D'Souza G; Darragh TM; Minkoff H; Colie C; Burian P; Palefsky J; Atrio J; Strickler HD
Am J Obstet Gynecol; 2016 Mar; 214(3):354.e1-6. PubMed ID: 26433170
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
10. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Castle PE; Solomon D; Schiffman M; Wheeler CM
J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
[TBL] [Abstract][Full Text] [Related]
12. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
[TBL] [Abstract][Full Text] [Related]
13. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
14. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
16. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
Schiffman M; Glass AG; Wentzensen N; Rush BB; Castle PE; Scott DR; Buckland J; Sherman ME; Rydzak G; Kirk P; Lorincz AT; Wacholder S; Burk RD
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1398-409. PubMed ID: 21602310
[TBL] [Abstract][Full Text] [Related]
17. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
Xi LF; Koutsky LA; Hildesheim A; Galloway DA; Wheeler CM; Winer RL; Ho J; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):4-10. PubMed ID: 17220325
[TBL] [Abstract][Full Text] [Related]
18. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.
Mirabello L; Sun C; Ghosh A; Rodriguez AC; Schiffman M; Wentzensen N; Hildesheim A; Herrero R; Wacholder S; Lorincz A; Burk RD
J Natl Cancer Inst; 2012 Apr; 104(7):556-65. PubMed ID: 22448030
[TBL] [Abstract][Full Text] [Related]
19. SNIPER: a novel assay for human papillomavirus testing among women in Guizhou, China.
Belinson SE; Wulan N; Li R; Zhang W; Rong X; Zhu Y; Wu R; Belinson JL
Int J Gynecol Cancer; 2010 Aug; 20(6):1006-10. PubMed ID: 20683409
[TBL] [Abstract][Full Text] [Related]
20. Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Lorincz AT; Castle PE; Sherman ME; Scott DR; Glass AG; Wacholder S; Rush BB; Gravitt PE; Schussler JE; Schiffman M
Lancet; 2002 Jul; 360(9328):228-9. PubMed ID: 12133661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
